CBD legal cannabis. Hemp products with less than one percent THC are not subject to Narcotics Act and are therefore increasingly exploited commercially. On the rise above all those containing CBD, which has no narcotic effects.
Hemp low in THC
The unauthorized use of hemp and hemp products with an average THC concentration of at least 1.0% is prohibited according to the DFI Ordinance on Drug Lists (OEStup-DFI, see link to ordinance in the "Legislation" sheet). However, there are several hemp products with a low THC content of less than one per cent that are not subject to the Narcotics Act. They include, in addition to raw materials such as flowers and hemp powder, also semi-finished products such as extracts in the form of oil or paste or the capsules offered wholesale and ready-to-use products such as food supplements, liquids for electronic cigarettes, substitutive products of tobacco, perfumed oils, chewing gum and ointments, partly offered as curative products.
Lately the production and sale of products with low THC content has increased considerably, and sets several health and legal issues. Although these products are not subject to the Narcotics Act, they can not be marketed and advertised freely. Depending on the category to which they belong, their industrial exploitation is applied to the law on therapeutic agents, the law on foodstuffs or the federal law for safeness of products. Therefore Swissmedic, the Federal Office of Public Health, the Federal Office of Food Safety and Veterinary and the Federal Office for Agriculture have realized an information sheet to raise awareness among potential bidders about the legal framework conditions (see document in This Page).
The hemp plant contains over 80 cannabinoids and over 400 other active ingredients. The most important cannabinoids are tetrahydrocannabinol (THC), with its amazing effects, and cannabidiol (CBD) which, besides not being a stupefacient, reduces the psychotropic effects of THC. The CBD is not subject to the Narcotics Act. Among the products with a low THC content, those with a higher CBD content are gaining importance. The supply is growing rapidly and the demand is increasing. There is talk, among other things, of possible therapeutic effects of the substance, which would have antioxidant, anti-inflammatory, anticonvulsant, anti-emetic, anti- anxiety and antipsychotic properties. Currently, the medical effect of CBD is not yet sufficiently substantiated by research (see also> medical use of cannabis containing THC).
Experts also discuss the possible use of hemp with a high CBD content, but less than one per cent of THC, as a substitute for the reduction of damage or for the treatment of problematic hemp consumption.
Hemp resin (hashish)
It should be noted that the sale of hemp products in the form of resin (hashish) is prohibited. For these products there is a general ban, even when they contain less than 1% THC (see OEStup-DFI, RS 812.121.11, list of controlled substances according to Article 2 paragraph 1, Annex 1). Products still on the market must be collected immediately and delivered to the cantonal pharmacist for destruction.